Accelerate Identification Of High-Producing Cell Lines

When companies are putting in place an upstream process, a critical step is generation of a cell line expressing the protein of interest. Unfortunately, the search for the best-producing clone is often compared with looking for a needle in a haystack. Making this more challenging is the pressure to get it right the first time, quickly and while mitigating risk and costs. Learn about our mini-pool approach and the value of automated systems to efficiently create, screen and isolate high producing clones with reduced costs.  Additionally, this approach allows us to confidently use material from the mini-pools to start process development which can reduce the workflow by approximately 10-13 weeks.

Watch our video with Research BDS Scientist Lucie Grindes from BioReliance® End-to-End Solutions, MilliporeSigma.